CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

amg 211

mAbexperimentalMulti-specific

Clinical trial activity

1 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Nov 27, 2014 (NCT02291614)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
Yes

Oral

No

Parenteral

No

Topical

No

Also known as

  • amg 211

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02291614Phase 1Nov 27, 2014Amgen, MedImmune
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AmgenFor profit1112014
MedImmuneFor profit1012014
2 organizations
Page 1 / 1